Journal of Bone and Mineral Research

Cover image for Vol. 32 Issue 3

Edited By: Juliet E Compston

Impact Factor: 5.622

ISI Journal Citation Reports © Ranking: 2015: 15/133 (Endocrinology & Metabolism)

Online ISSN: 1523-4681



Author Guidelines


JBMR® Introduces Graphical Abstracts

The Journal of Bone and Mineral Research is excited to offer Graphical Abstracts to interested authors wishing to introduce and expand on their research in a more visual and dynamic way!

Graphical Abstract

To view additional examples of our latest Graphical Abstracts please visit the JBMR Early View page.

COVER IMAGES. Authors wishing to submit images for consideration for use on the front cover of the JBMR® are encouraged to do so. Images and questions regarding cover images should be emailed to JBMRoffice@wiley.com.

JBMR® Announces Change to Article Fees - September 1 2016

Effective from September 1, 2016, the Journal of Bone and Mineral Research color page-fee charges will be replaced with a flat fee. ASBMR members will pay $1,200 USD and non-ASBMR members will pay $1,800 USD per published manuscript, which includes unlimited color images. All other charges will remain the same, including the manuscript submission fee of $50 USD, and the open access online open fee of $3,000 USD.

Quick Links

ARRIVE, CONSORT, STROBE, PRISMA checklists

Editorial Policies

Author rights for reuse and open access

Types of manuscripts published

Preparation and submission of manuscripts

Organization and format of manuscripts

Review process and decisions timeline

Publication fees


EDITORIAL POLICIES

COPE

The JBMR® is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE) www.publicationethics.org.

Author Agreement: The conflict of interest (COI) and copyright transfer (CTA) portions of the current Author Agreement can now be completed electronically as a web form, eliminating the need for authors to print, scan and upload a PDF form upon submission.

• COI information will be collected during submission via an online questionnaire on ScholarOne.

• The CTA will be completed at manuscript acceptance: If a manuscript is accepted for publication, the corresponding author will receive an e-mail prompt to log in to Author Services. Author Services is a Wiley web application that provides production tracking, as well as other resources for authors. From this site, corresponding authors can complete the CTA on behalf of all authors on the paper.

Copyright. The JBMR® is the official journal of the American Society for Bone and Mineral Research (ASBMR), which holds copyright to all material published in the Journal except as noted in the Author Agreement.

If your paper is accepted, the corresponding author will be able to complete the license agreement on behalf of all authors on the paper via the Wiley Author Licensing Service (WALS).

Employees of the US National Institutes of Health (NIH) may use the NIH Publishing Agreement in lieu of the standard author agreement JBMR®

Gold Open Access - OnlineOpen. The JBMR® offers authors an open access option called OnlineOpen, to have their article immediately freely available to everyone, including those who don’t subscribe. To cover the cost of publishing OnlineOpen, authors pay an article publication charge (APC). The APC for this journal can be found on Wiley’s OnlineOpen Pricing page. For more details, click here.

Authorship and Acknowledgment of Contributors. The JBMR® has adopted the requirements for authorship and acknowledgment of contributors recommended by the International Committee of Medical Journal Editors (ICMJE) in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, August 2013 update.

All manuscripts submitted to the JBMR® must adhere to the following requirements:

• Those listed as authors must have each 1) made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) participated in drafting the manuscript or revising it critically for important intellectual content; 3) approved the final version of the submitted manuscript, and 4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

• The respective roles of each author must be summarized in the Acknowledgments section of the manuscript.

• One or more of the authors must accept responsibility for the integrity of the data analysis and that author/those authors must be identified as such in the Acknowledgments section of the manuscript.

• All persons who have made substantial contributions to the work reported in the manuscript (e.g., data collection, analysis, writing, or editing assistance), but who do not fulfill the requirements for authorship specified above, must be named, with their specific contributions, in the Acknowledgments section of the manuscript.

• The authors must obtain the permission of all those who are identified in the Acknowledgments section of the manuscript.

• One author will serve as the primary correspondent (corresponding author) for the manuscript; the corresponding author is responsible for transmitting the editors’ comments to his or her co-authors.

• Authorship may not be modified after an article is accepted. Changes to the author list after submission must be detailed and justified in the cover letter.

Authors should note that the JBMR has adopted the following statement of policy based on a similar statement in the Information for Authors of the Annals of Internal Medicine:

Medical writers and pharmaceutical industry employees can be legitimate contributors to a manuscript. It is, however, particularly important that the roles, affiliations, and any potential conflicts of interest of all such contributors be included in the Acknowledgments section of the manuscript when it is submitted to the JBMR®. The editors consider that failure to acknowledge such contributors constitutes ghost authorship, which is contrary to the editorial policy of the JBMR®.

Disclosures/Conflicts of Interest. The JBMR® follows ICMJE guidelines for disclosure of potential conflicts of interest, and every paper published in the JBMR® includes a “Disclosures” section.

Scientific Misconduct. If an author violates any of the Journal’s policies described above, the editors may reject the manuscript, impose a moratorium on the consideration of new manuscripts from the authors, issue a statement of concern, or retract an already-published article. In addition, the editors may contact the Office of Research Integrity and/or an official at the authors’ home institution.

Duplicate/Redundant Publication. The corresponding author is responsible for ensuring that the manuscript — including all data, figures, tables, and supplementary materials — has not been previously reported or published. Further, it is the responsibility of the corresponding author to ensure that the manuscript has not been, and will not be, submitted to another journal while under review by the JBMR®. Original Articles providing new data from studies that have been the subject of previous publications must avoid overlap in the data reporting and authors must provide information on all relevant publications in their cover letter to the Editor-in-Chief.

Plagiarism and Image Integrity. The JBMR® utilizes Ithenticate to check submitted manuscripts to ensure that the text has not been plagiarized. Figures will also be scrutinized by the editors to ensure that images have not been inappropriately manipulated.

Clinical Trials. Clinical Trials submitted for publication in the JBMR® must conform to the Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials published by the American Association of Medical Colleges (AAMC). Authors should carefully read the AAMC Principles to ensure that their manuscripts are in full compliance, noting in particular the following:

•Authors of Clinical Trial manuscripts must indicate, in the cover letter, whether the study has conformed to a pre-specified analysis.

•Authors of Clinical Trial manuscripts must agree to provide the protocol and pre-specified analysis plan, along with amendments to and deviations from the plan, if requested by the JBMR® editors.

•Trial registration must include the minimum amount of trial information as defined by the World Health Organization (WHO) Trial Registration Data Set (see www.who.int/ictrp/network/trds/en/index.html).

Human Subjects/Declaration of Helsinki. Research carried out with human subjects must comply with the World Medical Association Declaration of Helsinki — Ethical Principles for Medical Research Involving Human Subjects. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body that gave approval. Identifying information of human subjects within written descriptions, photographs, or pedigrees should not be published. Additionally, clinical research studies must be registered with the appropriate national body (see www.wma.net/en/30publications/10policies/b3/17c.pdf).

STROBE: Authors of manuscripts reporting results of human observational case-control, cohort, or cross-sectional studies are required to upload the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) checklist at submission.

Use of Animals in Research. To be considered for publication in the JBMR®, research carried out on animals must be in compliance with the guiding principles in the Guide for the Care and Use of Laboratory Animals: Eighth Edition, ISBN-10: 0-309-15396-4. Approval by the appropriate institutional animal care and oversight committee must be indicated in the Methods, along with full husbandry and experimental details (e.g. strain, sex, replicate number, the method used to calculate the sample size and power of analysis) as indicated by the Animal Research Reporting of In Vivo Experiments (ARRIVE) checklist.

ARRIVE: Authors submitting research on animal studies are required to complete an adapted ARRIVE Animals in Research: Reporting In Vivo Experiments checklist with their submission.

CONSORT: Authors of manuscripts reporting results of clinical trials are required to upload the CONSORT (Consolidated Standards of Reporting Trials) checklist with their submission.

PRISMA: Authors of manuscripts reporting results of systematic reviews and meta-analyses are required to upload the PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist with their submission.

While publication of Human Genetic Study discoveries is a central element for disseminating knowledge, the Journal’s responsibility is to ensure that the design, analysis, and interpretation of the results of human genetic studies published in the Journal meet key aspects of scientific rigor similar to those stipulated by the STrengthening the REporting of Genetic Associations (STREGA) statement. Please click here to read the full guidelines on Human Genetic Studies.

Availability/Disclosure of Materials and Methods and Author Access to Data. Authors of papers submitted to the JBMR® must make materials and methods (e.g., cell lines, hybridomas, DNA clones, antibodies, biological reagents, and animal models) described in articles published in the JBMR® available to scientists in non-commercial institutions for purposes of replicating reported studies. Additionally, any original nucleotide/amino acid sequence data presented in a manuscript must be submitted to GenBank www.ncbi.nlm.nih.gov/genbank by the authors, and the accession numbers must be included with the submitted manuscript.

AUTHOR RIGHTS FOR REUSE AND OPEN ACCESS

Self-archiving Policy

Authors may self-archive the peer-reviewed (but not final) version of their paper on their own personal website, in their company/institutional repository or archive, and in not-for-profit subject-based repositories such as PubMed Central, following an embargo period of 12 months for scientific, technical, or medical journals. The version posted may not be updated or replaced with the VoR (Version of Record, which is the final, published version) and must contain the text, "This is the accepted version of the following article: [FULL CITE], which has been published in final form at [Link to final article]."

Funder Arrangements and Article Repositories

Certain funders, including the NIH, members of the Research Councils UK (RCUK), and Wellcome Trust require deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set out at the following website www.wiley.com/go/funderstatement. Please contact the Journal production editor if you have additional funding requirements.

The JBMR® supports its authors by depositing the accepted version of articles by National Institutes of Health (NIH) grant-holders to PubMed Central upon acceptance by the journal. Authors must first indicate during the submission process that their work was funded by the NIH.

1. Wiley (as publisher of JBMR®) automatically deposits the accepted version to PubMed Central (PMC) 2 to 4 weeks after manuscript acceptance.

The accepted version is the version that incorporates all amendments made during peer review, but prior to the publisher’s copy editing and typesetting.

2. PMC issues an NIHSMID number and sends an email to the corresponding author to approve submission. The corresponding author’s approval is a critical step in the process.

3. Three months after publication of the version of record (VoR), PMC issues the PMCID.

The VoR is the definitive published version of the article that appears in a paginated issue. The VoR has had value added by the publisher such as copyediting, formatting, etc. to become a living part of the scholarly record.

4. Twelve months after publication of the VoR, the accepted version appears in PubMed Central.

The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008.

NIH authors may also choose the OnlineOpen service as another option for NIH compliance. Upon payment of the OnlineOpen article publication charge ($3,000), Wiley will deposit the VoR into PubMed Central, with public availability in PubMed Central and the JBMR® website immediately upon publication.

OnlineOpen

OnlineOpen fulfills RCUK, Wellcome Trust, NIH, FWF, Telethon Italy, and other funder mandates. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is open access and freely available to all on Wiley Online Library. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. For the full list of terms and conditions, see: http://olabout.wiley.com/WileyCDA/Section/id-406241.html.

The fee for OnlineOpen in JBMR® is $3,000 US. OnlineOpen is activated upon payment and can be ordered at any point prior to, or after, acceptance. To make your article OnlineOpen, please complete the OnlineOpen Form.

For Authors Choosing OnlineOpen

If your paper is accepted, the author whom you identify as being the corresponding author for the paper will be presented with the option to sign an open access agreement (on behalf of all co-authors) to make the article available under the terms of the Creative Commons Attribution-Non-Commercial-NoDerivatives (CC-BY-NC-ND) license. For more information on the terms and conditions of the license please visit:

http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

The open access agreement is administered electronically. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK), you will be given the opportunity to publish your article under a Creative Commons Attribution License OAA (CC-BY) license, which supports you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy, please visit:http://www.wiley.com/go/funderstatement and the “Creative Commons Attribution License”section posted on http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

TYPES OF MANUSCRIPTS PUBLISHED

Original Articles. Original Articles should be kept to within approximately 28 double-spaced pages of 12-point Times Roman text, including the text of the manuscript, references, figures, figure legends, tables, and table footnotes.

Clinical Trials. Manuscripts reporting clinical trials should be kept to within approximately 28 double-spaced pages of 12-point Times Roman text, including the text of the manuscript, references, figures, figure legends, tables, and table footnotes.

Short Reports. Short Reports are brief descriptions of a focused study, the subject of which is especially timely or of high impact. Such communications should be limited to 1,500–1,800 words and include no more than two supporting figures or tables and 20 references.

Case Reports and Clinical Vignettes. Case Reports and Clinical Vignettes are discrete articles (1,500–1,800 words) that provide highly significant new insights into the pathophysiology of disorders of bone, muscle, and mineral metabolism and/or highlight new practical diagnostic/therapeutic considerations.

Letters to the Editor. The JBMR® welcomes Letters to the Editor that contribute constructively and substantively to scientific dialogue. Letters should address timely and important issues raised in articles recently published in the JBMR® and should be no more than 900 words. Note that the JBMR® only considers Letters to the Editor that comment on papers previously published in the Journal and letters may not contain unpublished data.

Reviews and Mini-Reviews (Perspectives). The JBMR® publishes Reviews and Perspectives (Mini-Reviews) on topics selected by the editors. Reviews are approximately 6,000 words in length and Perspectives are approximately 2,800 words. Authors should not submit Reviews or Perspectives without first contacting the JBMR® Editorial Office.

Commentaries. Commentaries are manuscripts that reflect on a featured article(s) published in the JBMR®. Commentaries are 1,500-2,000 words in length (12-point Times Roman), and one figure may be included. Commentaries are invited by the editors and unsolicited commentaries are rarely published. Authors should not submit Commentaries without first contacting the JBMR® Editorial Office.

Novel Hypotheses. Novel Hypotheses are conceptual papers that present intriguing concepts with biological plausibility and some supportive evidence, i.e., novel data and based on review of literature. Authors are encouraged to provide suggestions for future research to explore the hypothesis. Novel Hypotheses should not exceed 2,000 words. Authors should not submit Novel Hypotheses without first contacting the JBMR® Editorial Office.

Viewpoints. JBMR® Viewpoint articles provide commentary on topical issues arising in the field that the editors believe deserve immediate discussion and dissemination. Ordinarily, Viewpoints are invited by the editors. Authors should not submit viewpoints without first contacting the JBMR® Editorial Office.

PREPARATION AND SUBMISSION OF MANUSCRIPTS

This section presents detailed instructions on how to prepare and submit a manuscript to the JBMR®. Questions may be addressed to the JBMR® Editorial Office. Manuscripts that do not conform to the JBMR®’s policies or requirements, including requirements for manuscript organization, format, and figure and image size and quality will be returned to the authors without review.

Manuscript Submission. Manuscripts must be submitted to the JBMR® via the Journal’s online submission system by a single corresponding author at https://mc.manuscriptcentral.com/asbmr. Only the designated corresponding author will be able to view the submission’s status or make changes to the manuscript. If you change the corresponding author during submission, the manuscript will be removed from your account and placed into theirs. There can be only one corresponding author per manuscript.

Authors are now required to provide both a clean and marked-up version of each revision.

Questions about manuscript submissions should be directed to the JBMR® Editorial Office, jbmroffice@wiley.com.

JBMR® asks authors to classify their manuscript at the time of submission as Basic, Clinical, or Translational:

• Basic: a study limited to in vitro studies of cell biology, molecular biology, etc.

• Clinical: a study with the major component of the work involving human subjects

• Translational: any study involving predominantly animal models or where the laboratory and clinical aspects of a human study are of approximately equal weight.

Manuscript Details. Your manuscript may be submitted as a PDF file with figures and tables embedded at original submission. We will require that all files used to create the PDF, including figures, be submitted separately when a revision is requested. All manuscript pages must be numbered consecutively in the bottom right-hand corner, including references, tables, and figure legends.

Should a revision be requested, you will be required to upload your manuscript and table(s) in .doc/.docx format, and figures will be required to be uploaded separately as .tif or .eps files.

English-language Services. If you are not a native English speaker, Wiley Editing Services provides resources to help improve the English of your paper before submission.

Authors in Japan may visit Wiley-Japan for additional resources and information at http://www.wiley.co.jp/journals/editcontribute.html.

Authors in China are encouraged to visit Wiley-China at http://www.wiley.com/WileyCDA/Section/id-WILEYCHINA.html.

Nomenclature. Abbreviations and nomenclature must follow the recommendations of the International Union of Biochemistry. Use of the International System of Units (SI units) is required; include appropriate conversion factors to aid the reader where appropriate. Drug names should always be generic.

Papers on or that make use of bone histomorphometry must use the nomenclature, symbols, and units as described at Dempster et al.

Papers that include micro–computed tomography (?CT)-derived bone morphometry and density measurements in animal models must cite and use the nomenclature, symbols, and units as described in Bouxsein et al.

Papers on the descriptive epidemiology of osteoporosis should, wherever possible, include bone mineral density measurements made at the femoral neck and should report T-scores or diagnostic categories derived from standardized measurements using the NHANES III reference base for Caucasian women.

Abbreviations and Acronyms. Nonstandard abbreviations must be spelled out at first mention, with the abbreviated form appearing in parentheses. Thereafter, they should be used without definition. Standard JBMR® abbreviations do not need to be defined.

ORGANIZATION AND FORMAT OF MANUSCRIPTS

The order of manuscript elements is as follows:

• Cover Letter

• Title Page

• Disclosure Page

• Abstracts

• Introduction

• Materials and Methods

• Results

• Discussion

• Acknowledgments

• References

• Figure Legends

• Tables

• Figures

• Supplemental Data

Descriptions of each manuscript element are provided below.

Cover Letter. The cover letter should briefly outline the major findings of the study and the potential significance of these findings in the fields of bone and mineral research. Additionally, the authors may elect to indicate suggested reviewers in their letter, along with any reviewers to whom they might be opposed.

Title Page. The title page must include the title, names of the authors (in the same order as the manuscript) and their major degrees, and affiliations and grant supporters.

The corresponding author’s address, telephone number, and email address must also be provided. Finally, this page must indicate if any supplemental data have been included with the submission.

Important: All those listed as authors must meet the requirements specified in the “Authorship” section under “Editorial Policies,” above. All those who qualify for authorship must be listed.

Disclosure Page. Disclosures must be included at the time the manuscript is initially submitted to the JBMR®. JBMR® follows ICMJE requirements, and authors will be required to sign and fill out a disclosure eform, which incorporates the ICMJE requirements at the time of submission.

Title. The title must be concise and should accurately reflect the scope of the study, including the species investigated. Editors reserve the right to edit titles that are not clear and succinct.

Abstract. An abstract that briefly summarizes the major findings of the study must be included. It must be unstructured (i.e., there should not be introduction, methods, results sections, etc.), self-explanatory (i.e., completely understandable without reference to the text of the manuscript), and must not exceed 300 words. Five key words should be listed at the bottom of the Abstract page. Click here for a full list of key words.

Introduction. This section should concisely review the rationale for the study and identify what issues are to be addressed. Background information directly pertaining to and necessary for the understanding of the study should also be included. This should clearly place the article within the area being studied and should not describe the outcome of the study in any detail.

Materials and Methods. This section should carefully describe the methods and materials used, including statistical approaches (see below). It is not necessary to describe commonly used techniques in detail. Experiments must be outlined in sufficient detail to enable repetition by others, including the sequence and source of unique constructs. Any limitation of authors to full data access (e.g., blinded, etc.) must be explained. Restrictions on access to materials or experimental animals should be specified (for details, see "Use of Animals in Research" and“Availability/Disclosure of Materials and Methods and Author Access to Data”).

Results.This section should succinctly state the results without lengthy discussion or interpretation of individual data. Graphical format is often preferable to tabular presentation of data.

Statistical Analysis. Authors are responsible for ensuring that data presented in a manuscript are reproducible and that any differences in these data, upon which the authors draw conclusions, are not merely the result of random variation, (i.e., are statistically significant). Statistically significant findings are not prerequisites for publication in the JBMR®; however, properly analyzed data indicating null association or null effect can also be highly informative and publishable.

Since statistical analyses vary according to study design and prohibit the establishment of standard rules, guidelines are available here to assist authors in performing the most appropriate statistical analyses and reporting those results in accord with JBMR® standards.

Discussion. Study results should be summarized, though not repeated in detail, to provide context for logical explanations of the reported results and extrapolations or hypotheses drawn from them. The Discussion should conclude by re-stating the major findings of the study in relation to the rationale and aims of the study as outlined in the introduction. A concluding remark regarding wider implications of study findings is expected.

Acknowledgments. Authors must acknowledge all support for the work, including funding, materials, equipment, drugs, technical assistance, etc. Acknowledgments should conform to the requirements detailed in the “Editorial Policies/Authorship and Acknowledgment of Contributors”section.

In addition, the JBMR® requires that each author briefly summarize his or her respective role. Example:

Authors’ roles: Study design: TC and DD. Study conduct: RF. Data collection: AF. Data analysis: RF and AF. Data interpretation: TC, DD, RF, and AF. Drafting manuscript: TC and DD. Revising manuscript content: RF, and AF. Approving final version of manuscript: TC, DD, RF, and AF. RF takes responsibility for the integrity of the data analysis.

References. Authors are responsible for the accuracy of their references. References must be numbered consecutively in the order they appear in the text. Place each reference number in parentheses, throughout the text, tables, and legends. Use parentheses, as in this example (1). If the same reference is used again, re-use the original number.

Please click here to view our Reference Style Sheet.

Figure Legends. A separate list of figure legends must be supplied at the end of the manuscript. These should provide sufficient information for the figure to be understood independent of the text. Do not include these legends in the figure files themselves.

Tables. Tables should complement the text without reiterating it. Tables should be numbered consecutively according to the order in which they are cited in text. Each table should have a brief, descriptive title. All necessary information should be contained in the footnote, and the table itself must be understandable independent of the text. Tables should not contain color. Provide each table column with an appropriate heading, and indicate clearly any units of measurement in the table. A key should be provided in the footnote for any symbols used. Tables may be embedded into the manuscript DOC or DOCX file. Superscript notation using sequential letters to indicate statistical significance (e.g., 342 ± 14a) is preferable to the use of non-sequential symbols.

Figures. Figures should be labeled with Arabic numerals (Figure 1, 2, etc.) and panels labeled with letters (A, B, C). The JBMR® allows the use of videos as primary figures; in order to do so, you must submit a screen capture from the video for use in the printed version of the Journal. The y-axis of graphs should originate at 0 or should show a clear scale break in cases where this would be difficult.

Figures should be sized to one-column width (20 picas, 84 mm), or two-column width (42 picas, 177 mm), as appropriate. Multi-panel images should be composed as a single image with width and height limitations applying to the final, combined image. Image resolution must be at least 300 dpi for raster images (e.g., photographs, gels, stains) and 600 dpi for line-art images (e.g., charts and graphs). Image-related text and labeling must be clearly legible in a font size of 10 points or greater Times New Roman in the final image.

Images presented in figures must adhere to the Guidelines for Best Practices in Image Processing: http://ori.hhs.gov/education/products/RIandImages/guidelines/list.html.

Figures should not include figure legends. Figures must be submitted in TIF or EPS formats. The JBMR® cannot accept figures in PDF, PPT, or PPTX formats because the quality of print reproduction of figures in these formats is poor. For further guidance on preparing digital figure files, author(s) are encouraged to visit http://cjs.cadmus.com/da/applications.asp.

Supplemental material. Supplemental material may be submitted to accompany an article for online-only publication when there is insufficient space or it is not possible to include the material in print. Supplemental materials will also be reviewed and controlled for plagiarism and falsification.

Supplemental material must be uploaded separately from the manuscript and figures. Unless specifically requested by the editors during the review process, supplemental material must be submitted along with the manuscript and not after the peer review process has begun or has been completed. The JBMR® will not accept supplemental material after an article has been accepted. Supplemental figures and tables must be referenced in the manuscript and appropriately labeled, i.e., “Supplemental Figure 1,” “Supplemental Figure 2,” etc.

Although the JBMR® does not set strict limits on the amount of supplemental material, authors should make efforts to keep the amount of such material to a reasonable level and submit only what is necessary to improve the communication of the paper’s key scientific points.

Please note that supplemental information will be subjected to the full review process, but will not be checked for typographical errors or technical functionality. The responsibility for such errors and file functionality remains entirely with the authors. A disclaimer will be displayed to this effect with any supplemental information published. Questions about missing supporting information on Wiley Online Library should be directed to the journal's production editor.

Wiley does not provide technical support for the creation of supporting information. For more information, please see http://authorservices.wiley.com/bauthor.

REVIEW PROCESS AND DECISIONS TIMELINE

The JBMR® receives more than 800 submissions annually and must therefore be highly selective. The editors typically accept no more than around 25% of the manuscripts submitted each year. Manuscripts that the editors judge unlikely to be accepted may be returned to the authors without peer review. After acceptance, the time to online publication of the non-copyedited “Accepted Article” version of a paper is typically two weeks.

Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Once your article is published, Wiley offers a variety of tools to help you track impact and manage publicity. Please see the Author Toolkit for more information.

PUBLICATION FEES

Submission Fee. The JBMR® charges a fee of $50.00 US for all unsolicited submissions with the exception of revised manuscripts, invited Reviews and Commentaries, and Letters to the Editor. Please click here to access the online Manuscript Submission Fee Form.

ASBMR can no longer accept faxed or emailed credit card payments. To pay your manuscript submission fee with credit card, please visit the ASBMR website. To pay with check or to request an invoice, please email asbmr@asbmr.org.

Publication fees. Effective from September 1, 2016, the Journal of Bone and Mineral Research (JBMR®) color page-fee charges will be replaced with a flat fee. ASBMR members will pay $1,200 USD and non-ASBMR members will pay $1,800 USD per published manuscript, which includes unlimited color images. All other charges will remain the same, including the manuscript submission fee of $50 USD, and the open access online open fee of $3,000 USD. Invited material is not subject to article publication charges.

SEARCH

SEARCH BY CITATION